AB035. Validation of EORTC brain cancer module (EORTC QLQ-BN20) for assessment of health-related quality of life in glioma patients in Singapore
This study supports the validity and reliability of the EORTC QLQ-BN20 among patients with glioma in Singapore. There is good convergent and discriminant validity, internal consistency, construct validity, and clinical validity. The QLQ-BN20 is a valuable supplement to the QLQ-C30. Hence, we recommend expanding its use for all glioma patients and possibly brain cancer patients in Singapore.
Authors
- Vincent Diong Weng Nga (ORCID: https://orcid.org/0000-0001-5256-5669)
- Jaclyn Tan (ORCID: https://orcid.org/0000-0001-7392-9345)
- Shiong Wen Low (ORCID: https://orcid.org/0000-0002-7506-2949)
- Tseng Tsai Yeo (ORCID: https://orcid.org/0000-0003-4376-5153)
- Mervyn Jun Rui Lim (ORCID: https://orcid.org/0000-0002-6866-9531)
- Nan Luo (ORCID: https://orcid.org/0000-0001-7980-6979)
- David A. Low (ORCID: https://orcid.org/0000-0001-7677-8634)
- Xuling Lin (ORCID: https://orcid.org/0000-0001-9551-7659)
- Y. Koh (ORCID: https://orcid.org/0009-0005-7482-5835)
- Kejia Teo (ORCID: https://orcid.org/0000-0003-4586-1683)
- G. Ang
- Samantha Ang
Institutions
- National University of Singapore (SG)
- National University Hospital (SG)
- National University Health System (SG)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/cco-24-ab035
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00